Purpose Epilepsy is more common in people with intellectual disabilities than in the general
population. However, reported prevalence rates vary widely between studies. This …

Epilepsy is a disease where disparities and inequities in risk and outcomes are complex and
multifactorial. While most epilepsy research to date has identified several key areas of …

Aims The drug burden index (DBI) is a dose‐related measure of anticholinergic and
sedative drug exposure. This cross‐sectional study described DBI in older adults with …

Background Research indicates that adults with intellectual disabilities are living longer.
However, there is limited research on how this affects health and care needs. Objective The …

Background There is paucity of research from Australia about comorbidity in older people
with intellectual disability (PwID). This paper examines the burden of chronic diseases and …

Background Adults and older people with intellectual disabilities (ID) frequently receive anti-
cholinergic drugs in chronic use, but no studies in Italy to date have investigated cumulative …

BackgroundNo studies to date have investigated cumulative anticholinergic exposure and
its effects in adults with intellectual disabilities. AimsTo determine the cumulative exposure …

This study examined the health service utilization and hospital treatment cost of individuals
with epilepsy by age group, mortality within 30 days, and surgical outcomes for individuals …

Purpose Epilepsy is highly prevalent in people with intellectual disabilities and mortality is
increased in people with epilepsy generally. This review summarises research on the …

Background People with intellectual disabilities (ID) have complex pharmaceutical care
needs due to a high prevalence of multimorbidity, a notable degree of polypharmacy and a …